End-to-end support across the product lifecycle — from pre-launch evidence strategy to post-launch commercial optimisation. AI-enhanced delivery. Regulatory rigour. Pharma-industry veterans at every level.
From pre-launch planning to lifecycle optimisation, we deliver the strategic and tactical Medical Affairs support that drives clinical differentiation and commercial success.
Integrated medical plans aligned with brand strategy. We define objectives, tactics, and KPIs that connect Medical Affairs activity to measurable business outcomes.
Comprehensive pre-launch and launch medical planning. Stakeholder mapping, competitive intelligence, cross-functional alignment, and the materials your field teams need from Day 1.
Expert medical writing across every format — from congress materials to peer-reviewed manuscripts. All content is scientifically rigorous and MLR-ready.
Keep your product competitive throughout its lifecycle. Indication expansion support, competitive response strategies, and ongoing tactical optimisation.
Robust evidence strategies that satisfy regulators, convince payers, and empower your field medical teams. From protocol design to publication-ready results.
Define the evidence your product needs at each lifecycle stage. We map evidence gaps against stakeholder requirements — regulators, HCPs, payers, and patients.
Pragmatic real-world studies that demonstrate effectiveness beyond the clinical trial setting. Registry studies, claims analyses, and patient-reported outcomes.
Clinical study leadership from protocol to publication. Investigator-Initiated Trial support including proposal evaluation, protocol guidance, and study oversight.
Rigorous evidence synthesis to support regulatory submissions, payer dossiers, and scientific communications. PRISMA-compliant and publication-ready.
Promotional and non-promotional content that translates complex clinical data into clear, compliant messaging. Built to pass MLR first time.
Evidence-grounded value propositions and core claims that resonate with HCPs and differentiate your product. Messaging hierarchies built for global-to-local adaptation.
Integrated campaigns across digital, field, congress, and advisory board channels. From email sequences to e-learning modules — always on-brand, always compliant.
Equip your reps with the materials they actually use. Detail aids, objection handlers, clinical data summaries, and leave-behind resources that drive conversations.
Unbranded disease awareness campaigns for HCPs and patients. Adherence programmes, injection training resources, and patient support content.
Build the evidence and narratives that secure formulary access, favourable NICE/SMC outcomes, and optimal positioning with payer stakeholders across markets.
Comprehensive value dossiers for NICE, SMC, AWMSG, and international HTA bodies. Cost-effectiveness models, budget impact analyses, and submission-ready packages.
Robust economic models that demonstrate the value of your product to health systems. Cost-effectiveness, budget impact, and cost-consequence analyses tailored to each market.
Translate clinical data into the language payers understand. Economic value narratives, formulary submission packs, and payer-facing slide decks.
Multi-market access strategies across UK, EU5, and global markets. Stakeholder mapping, reimbursement landscape analysis, and launch sequencing recommendations.
Responsive, accurate, and compliant medical information support — from standard response documents to real-time HCP enquiry handling and pharmacovigilance collaboration.
Development and maintenance of SRDs covering frequently asked questions from HCPs, pharmacists, and patients. Evidence-based, regularly updated, and MLR-approved.
Expert-reviewed responses to unsolicited HCP and patient enquiries. On-label and off-label question handling with appropriate scientific balance and compliance guardrails.
Adverse event identification, triage, and reporting collaboration. Integration with your PV function for seamless safety signal management.
Accelerate SRD development and enquiry handling with AI-powered evidence retrieval, draft response generation, and automated reference checking — always with expert human review.
Actionable insights that inform strategy. Primary and secondary research designed by people who understand what pharma brand teams and Medical Affairs functions actually need.
Qualitative and quantitative research with HCPs, payers, patients, and internal stakeholders. Discussion guide design, fieldwork oversight, and insight synthesis by therapeutic area experts.
Real-time monitoring of competitor activity — pipeline, messaging, KOL engagement, congress presence, and market positioning. Delivered as actionable intelligence, not raw data.
Understand patient flows, prescribing behaviours, and unmet needs across your target markets. Secondary data synthesis combined with expert clinical interpretation.
Test your positioning, claims, and creative concepts with target audiences before you commit to full-scale development. Rapid-cycle research that feeds directly into your content strategy.
Strategic thought leader engagement that builds authentic, compliant, and productive relationships — from identification and profiling through to advisory board execution.
Data-driven identification of key opinion leaders, rising stars, and digital opinion leaders using publication analysis, congress activity, clinical trial involvement, and social media presence.
Tiered engagement plans that match the right activities to the right thought leaders. Speaker programmes, advisory boards, publication collaborations, and educational partnerships.
End-to-end compliance support for KOL engagements. Contract templates, FMV assessments, transparency reporting, and disclosure management aligned with ABPI/EFPIA requirements.
ABPI Final Signatory oversight and MLR review expertise. We ensure every piece of content — promotional and non-promotional — meets the highest compliance standards.
Medical-Legal-Regulatory review of all promotional and non-promotional materials. ABPI Final Signatory certification with rapid turnaround and clear, actionable feedback.
Evidence grading, reference verification, and fair balance assessment. We ensure every claim is defensible, every reference is accurate, and risk information is appropriately presented.
Navigate the complexity of cross-border compliance. ABPI, EFPIA, PhRMA, IPHA, and FDA/EMA requirements — we ensure your materials work across jurisdictions.
Practical AI implementation for pharmaceutical Medical Affairs and Marketing teams. Not theoretical — we've built and deployed the workflows ourselves.
Evaluate your processes, data infrastructure, and team capabilities. Identify high-impact AI use cases with realistic ROI estimates and a phased implementation roadmap.
Deploy AI tools into your existing Medical Affairs and Marketing workflows. Literature monitoring, content generation, evidence synthesis, and quality checking — with proper governance.
Build AI literacy across your teams. Hands-on training in prompt engineering, output evaluation, and responsible AI use — tailored for pharmaceutical professionals.
Our services span the full pharmaceutical product journey — we're your partner from early development through to loss of exclusivity.
Evidence strategy, competitive landscaping, medical positioning
KOL engagement, advisory boards, MSL training, market shaping
Sales enablement, payer submissions, disease education, congress plans
Omnichannel campaigns, RWE studies, publication programmes
Indication expansion, competitive defence, lifecycle evidence
Value defence, franchise strategy, next-generation transition
Whether you need a single deliverable or an integrated programme across Medical Affairs, Marketing, and Market Access — we can help.